94 related articles for article (PubMed ID: 21166722)
1. Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure.
Martires KJ; Domingo DS; Hsia A; Fu P; Cooper KD; Baron ED
Exp Dermatol; 2011 Mar; 20(3):280-2. PubMed ID: 21166722
[TBL] [Abstract][Full Text] [Related]
2. Topical pimecrolimus 1% reverses long-term suberythemal ultraviolet B-induced epidermal Langerhans cell reduction and morphologic changes in mice.
Yin Z; Xu J; Lu Y; Luo D
J Drugs Dermatol; 2012 Sep; 11(9):e25-7. PubMed ID: 23135668
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of human epidermal Langerhans' cell B7-1 and B7-2 co-stimulatory molecules in vivo by solar-simulating irradiation.
Laihia JK; Jansen CT
Eur J Immunol; 1997 Apr; 27(4):984-9. PubMed ID: 9130654
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical pimecrolimus 1% on high-dose ultraviolet B-irradiated epidermal Langerhans cells.
Yin Z; Xu J; Zhang Z; Luo D
Int Immunopharmacol; 2012 Dec; 14(4):635-40. PubMed ID: 23079131
[TBL] [Abstract][Full Text] [Related]
5. Solar-simulating irradiation of the skin of human subjects in vivo produces Langerhans cell responses distinct from irradiation ex vivo and in vitro.
Laihia JK; Jansen CT
Exp Dermatol; 2000 Aug; 9(4):240-7. PubMed ID: 10949544
[TBL] [Abstract][Full Text] [Related]
6. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
[TBL] [Abstract][Full Text] [Related]
7. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin.
Baadsgaard O; Lisby S; Wantzin GL; Wulf HC; Cooper KD
J Immunol; 1989 Jun; 142(12):4213-8. PubMed ID: 2470820
[TBL] [Abstract][Full Text] [Related]
8. Production and clearance of cyclobutane dipyrimidine dimers in UV-irradiated skin pretreated with 1% pimecrolimus or 0.1% triamcinolone acetonide creams in normal and atopic patients.
Doelker L; Tran C; Gkomouzas A; Grand D; Sorg O; Saurat JH; Lübbe J
Exp Dermatol; 2006 May; 15(5):342-6. PubMed ID: 16630073
[TBL] [Abstract][Full Text] [Related]
9. Topical pimecrolimus inhibits high-dose UVB irradiation-induced epidermal Langerhans cell migration, via regulation of TNF-α and E-cadherin.
Yin Z; Xu J; Zhou B; Wu D; Xu Y; Zhang J; Luo D
Drug Des Devel Ther; 2014; 8():1817-25. PubMed ID: 25336924
[TBL] [Abstract][Full Text] [Related]
10. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin.
Camouse MM; Domingo DS; Swain FR; Conrad EP; Matsui MS; Maes D; Declercq L; Cooper KD; Stevens SR; Baron ED
Exp Dermatol; 2009 Jun; 18(6):522-6. PubMed ID: 19492999
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).
Panhans-Gross A; Novak N; Kraft S; Bieber T
J Allergy Clin Immunol; 2001 Feb; 107(2):345-52. PubMed ID: 11174203
[TBL] [Abstract][Full Text] [Related]
12. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
Grassberger M; Steinhoff M; Schneider D; Luger TA
Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
[TBL] [Abstract][Full Text] [Related]
13. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
14. Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation.
Lerche CM; Philipsen PA; Poulsen T; Wulf HC
Exp Dermatol; 2009 Mar; 18(3):246-51. PubMed ID: 19183401
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical tacrolimus 0.03% on long-term suberythemal ultraviolet B-irradiated epidermal Langerhans cells in mice.
Yin ZQ; Lu Y; Zhou BR; Guo Z; Luo D
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):521-3. PubMed ID: 22471949
[No Abstract] [Full Text] [Related]
16. Partial protection against epidermal IL-10 transcription and Langerhans cell depletion by sunscreens after exposure of human skin to UVB.
Hochberg M; Enk CD
Photochem Photobiol; 1999 Nov; 70(5):766-72. PubMed ID: 10568168
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of Langerhans cells in human reconstructed epidermis to known allergens and UV radiation.
Facy V; Flouret V; Régnier M; Schmidt R
Toxicol In Vitro; 2005 Sep; 19(6):787-95. PubMed ID: 15921883
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits DNA synthesis by epidermal Langerhans cells.
Haftek M; Urabe A; Kanitakis J; Dusserre N; Thivolet J
Reg Immunol; 1990-1991; 3(5):236-41. PubMed ID: 1716949
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells.
Hoetzenecker W; Meingassner JG; Ecker R; Stingl G; Stuetz A; Elbe-Bürger A
J Invest Dermatol; 2004 Mar; 122(3):673-84. PubMed ID: 15086553
[TBL] [Abstract][Full Text] [Related]
20. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Gisondi P; Ellis CN; Girolomoni G
Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
